We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Pharmaceutical patents case clarifies first authorisation

Pharmaceutical Law Insight

Pharmaceutical patents case clarifies first authorisation

Supplementary Protection Certificate appeal dismissed on reference to European case law

Pharmaceutical company Neurim appealed a decision to turn down its application for a Supplementary Protection Certificate. The higher court dismissed the appeal, and its judgment clarifies the European definition of first authorisation of a medicinal product.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?

Devices

Request a trial Find out more